UNSPSC 51341904: Maraviroc

This classification denotes a chemokine receptor antagonist and anti-hiv agent with the molecular formula C29H41F2N5O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MD6P741W8A, chemically known as uk-427,857 but generally known as maraviroc, which bears US NIH Compound Identifier 3002977. European Medicines Agency schedules Maraviroc in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25224.

UNSPSC 51341904 Maraviroc, a Commodity code, does not align with the recent state and local opportunities posted under this designation. The code nominally covers Maraviroc, an antiretroviral medication for HIV treatment, yet the four recent solicitations reflect procurement of naloxone, safe drug deactivation systems, general medical and first-aid supplies, and multi-source generic pharmaceuticals and over-the-counter products — none of which are Maraviroc or narrowly antiretroviral in scope. The mismatch suggests either systematic miscoding in the source data or that this code identifier is being applied to broader pharmaceutical supply categories in state and local systems. Based on the opportunities actually posted, state and local governments are buying emergency medical supplies, public health countermeasures, fire department equipment, and pharmacy benefit program products through county health departments, municipal purchasing offices, state health commissions, and cooperative purchasing alliances.

The geographic spread includes Florida, Texas, and Minnesota with multi-state reach through the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), which extends purchasing authority to Oregon and other participating jurisdictions. Representative recent opportunities include Seminole County, Florida's competitive bid (IFB60459723LAS, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually; the City of Tampa's sealed-bid procurement (26P00145, due March 13, 2026) for 169 line items of medical and first-aid supplies for its Fire Department Rescue Division with an estimated contract value of $700,000 and a small local business enterprise set-aside; the Texas Health and Human Services Commission's Request for Information (HHS0017013, posted April 3, 2026) on direct-to-manufacturer prescription programs; and MMCAP's Request for Proposal (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products across state and local facilities. If pursuing activity under this code, verify current coding accuracy with the issuing jurisdiction, as the nominal code definition does not reflect the pharmaceutical and medical supply procurement actually being tagged and solicited.